Chengdu Olymvax Biopharmaceuticals Inc(688319.SH) received the Phase III clinical study summary report for the recombinant Staphylococcus aureus vaccine (E. coli)
Olymvax Biopharmaceuticals Inc. (688319.SH) announced that the company recently received the Phase III clinical study summary report for the recombinant Staphylococcus aureus vaccine (E. coli) (the "recombinant S. aureus vaccine"). The recombinant S. aureus vaccine demonstrates significant and stable protective efficacy in preventing postoperative Staphylococcus aureus infections, can induce rapid and effective specific immune responses, and exhibits a favorable safety profile. The clear and favorable benefit-risk assessment supports its marketing application for the indication of "prevention of Staphylococcus aureus infections after orthopedic surgery."
Chengdu Olymvax Biopharmaceuticals Inc (688319.SH) announced that the company recently received the Phase III clinical study summary report for the recombinant Staphylococcus aureus vaccine (E. coli) (referred to as the "recombinant S. aureus vaccine"). The recombinant S. aureus vaccine demonstrates significant and stable protective efficacy in preventing postoperative Staphylococcus aureus infections, can induce rapid and effective specific immune responses, and exhibits a favorable safety profile. The clear and favorable benefit-risk assessment supports its marketing application for the indication of "prevention of Staphylococcus aureus infections after orthopedic surgery."
Related Articles
US Stock Market Move | To partner with Samsung to produce HBM base chips Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR (TSM.US) rises over 3%
Five major catalysts could drive the stock price up 40%! Morgan Stanley names Amazon.com, Inc. (AMZN.US) a top pick, raises price target to $350.
A-share Evening Highlights | "One Central Bank and Two Commissions and One Regulatory Body" Make Major Statements on Capital Markets, Monetary Policy, and More
US Stock Market Move | To partner with Samsung to produce HBM base chips Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR (TSM.US) rises over 3%
Five major catalysts could drive the stock price up 40%! Morgan Stanley names Amazon.com, Inc. (AMZN.US) a top pick, raises price target to $350.
A-share Evening Highlights | "One Central Bank and Two Commissions and One Regulatory Body" Make Major Statements on Capital Markets, Monetary Policy, and More
